Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

IGI and Fujisawa collaborate on topical formulations of dermatological product

Jan. 27, 2000

Micrologix Biotech commences phase I trial for acne therapy

Jan. 25, 2000

Access cleared to commence phase III OraDisc study in the U.K.

Jan. 25, 2000

Cellegy expands Anogesic clinical trial for reduction of pain in hemorrhoidectomy

Jan. 24, 2000

Preparation, use and pharmaceutical compositions of new Galderma compounds

Jan. 17, 2000

OrthoLogic initiates phase I/II trial of Chrysalin for accelerated tissue repair

Jan. 14, 2000

Corixa to commence phase II trials of PVAC for treatment of psoriasis

Jan. 13, 2000

Alexion files IND for C5 inhibitor trial in psoriasis patients

Jan. 13, 2000

Positive preclinical results reported for Maxim's oral mucositis gel

Jan. 12, 2000

Japanese patent covers new selectin inhibitors useful for inflammatory conditions

Jan. 11, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...